4 edition of Point estimates and bootstrap intervals of lead time in the National Breast Screening study found in the catalog.
Point estimates and bootstrap intervals of lead time in the National Breast Screening study
Helen Xun Xie
by National Library of Canada = Bibliothèque nationale du Canada in Ottawa
Written in English
|Series||Canadian theses = Thèses canadiennes|
|The Physical Object|
Percent mammographic density (PMD) is associated with an increased risk of interval breast cancer in screening programs, as are younger age, pre-menopausal status, lower body mass index and hormone therapy. These factors are also associated with variations in PMD. We have examined whether these variables influence the relative frequency of interval and screen-detected breast Cited by: In investigators started a study of the association between cholesterol levels and peripheral vascular disease in a group of 2, residents who had entered into a over residential planned community in At the time of their medical examination on entry into the community, each subject had a baseline cholesterol level drawn.
Anticipated breast cancer mortality reduction due to proper mammography screening For women aged the mortality rate is improved for screening at intervals less than two years. This is because the growth rate for cancer is typically faster for women in this age group. BACKGROUND: Previous studies have revealed conflicting results for the Breastfeeding Assessment Score (BAS) in predicting early breastfeeding cessation. Our objective was to externally validate the BAS and provide summary accuracy estimates for this clinical prediction model. METHODS: We used the original data from a prospective cohort by: 1.
Biennial screening is generally recommended for average-risk women aged 50 to 74 years, but tailored screening may provide greater benefits. Objective: To estimate outcomes for various screening intervals after age 50 years based on breast density and risk for breast cancer. Design:Cited by: Etzioni R, Gulati R, Mallinger L, Mandelblatt J. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med ; Coldman A, Phillips N. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
Promoting grassroots human and development rights in Africa
Ancestry of the children of Robert Croll Stevens and Jane Eleanor (Knauss) Stevens
Fish-cultural station, Maryland.
Mineralization in the waning Creede epithermal system, and similar behavior in other systems
Algebra (The University of Chicago School Mathematics Project)
U.S. market for writing instruments and art supplies
Gorsley & Kilcot
Knights of Rhodes
Harmony and analysis
Strengthening the free world through steps toward Atlantic unification
Listening and note-taking
Breast Screening study (NBSS) to estimate the mean lead time; the underlying inci- dence rate of breast cancer in the population; and the false negative rate of screening test. This tliesis is the first attempt to systematically evaluate the properties of es- timated screening parameters, construct tbeir confidence intervals and measure the associated biases of estimates using the bootstrap met hod.
Author: Helen Xun Xie. Most screening intervals were between and days. The proportion of women with ductal carcinoma in situ (DCIS) decreased significantly with increasing screening interval, from 24/94 (%) for Cited by: It is reported that 7 years after the start of screening in Sweden, the incidence of invasive breast cancer in the screened age group was 69% higher than expected (Duffy et al, ).
After adjustment for a lead time of years and for the increased use of hormone replacement therapy, they found 39% by: screening intervals on the reduction in breast carci-noma mortality.
Their model was possible in part be-cause there are data available in the literature that can be used to extract rough estimates of the rate of breast carcinoma growth and spread In particular, Michaelson et al. were able to. The National Guidelines for Breast Cancer Screening and Diagnosis Follow best practice for breast cancer screening and diagnosis care pathways and recommendation of breast cancer screening per Appendix 2,3; Adhere to the Clinical performance Indicators and timelines forFile Size: KB.
In a study of women aged 50 and over who were diagnosed with breast cancer between and in Wisconsin, before the time that mammography was recommended for women in their forties, % of cancers were reported by women as initially detected by CBE In a sec-ond study, % of breast cancers diagnosed be-Cited by: Time interval since last test in a breast cancer screening programme: A case-control study in Italy Article (PDF Available) in Journal of Epidemiology & Community Health 43(3) October.
A total of breast cancers were detected at mammographic screening (true-positive cancers) during the first 33 months of the program, and 37 interval cancers were identified during the plane of imaging on ultrasound of the breast that is perpendicular to the radial plane of imaging; the radial plane of imaging uses the nipple as the center point of an imaginary clock face imposed on the breast, such that the radial 12 o'clock plane is a line extending upward toward the top of the breast; similarly the radial 9 o'clock plane extends straight out to the right aspect of the.
The principle behind screening. Lead time: time by which diagnosis is brought forward as a result of early detection (from: Spix C, et al.: Lead-time and overdiagnosis estimation in neuroblastoma screening. Statist Med ; –92).
Excerpt Cited by: Objective To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes.
Design Prospective cohort study of Norwegian women who were followed between and Within that period (), a national mammography screening programme was gradually Cited by: These estimates were based on a long-term screening program from age 50 to For each six-month decrease in screening interval length, we estimated the percent increase in mean lead time, as well as the percent increase in the proportion of clinical patients who will have their cancer detected at Cited by: 2.
Breast Cancer Screening The Search for Consensus Presented for Paint it Pink Septem Nathaniel W. Cuthbert, MD.
Berg. Despite awareness of lead-time bias, the results of screening programs are reported regularly as triumphant, with stunning 5-year survival data (1). The estimates of lead-time bias vary between 1 and 4 years but they can never be accurate, given the effect of length bias (2).Cited by: so that all women of appropriate age have access to regular and ongoing screening for breast cancer.
The performance measurement for this clinical quality measure focuses on systems for Breast Cancer Screening for women of average risk, but work to improve performance on this measure will likely improve Breast Cancer Screening for all women. The Canadian National Breast Screening Study (NBSS) compared high-quality CBE plus mammography with CBE alone in women aged 50 to 59 years (refer to the Clinical Breast Examination section in the Overview section of this summary for more information).
CBE, lasting 5 to 10 minutes per breast, was conducted by trained health professionals, with periodic evaluations of performance quality. Bayesian Inference for the Lead Time in Periodic Cancer Screening Article in Biometrics 63(3) October with 31 Reads How we measure 'reads'.
Variance estimation and confidence intervals for the standardized mortality ratio with application to the assessment of a cancer screening program Article in Statistics in Medicine 30(25).
The National Cancer Institute defines “early stage breast cancer” as breast cancer that has not spread beyond the breast or axillary lymph nodes, that is stage IIIA or lower. From the perspective of screening, however, the goal is to find breast cancer before it has spread to axillary lymph nodes and, ideally, when it is under 2 cm in Author: Wendie A.
Berg.Breast Cancer Screening and Follow-Up Tests For more information, visit or call the Susan G. Komen breast care helpline at GO KOMEN () Monday through Friday, 9 AM to 10 PM ET. The above list of resources is only a suggested resource and is not a complete listing of breast cancer materials or information.
The. A meta-analysis of data from randomized clinical trials into breast cancer screening showed that women aged 50 to 70 years invited to screening had a 20% lower risk for breast cancer–related.